Literature DB >> 25015510

Henipavirus encephalitis.

Suhailah Abdullah1, Chong Tin Tan2.   

Abstract

Entities:  

Keywords:  Hendra virus; Henipavirus; Nipah virus; Pteropus bats; encephalitis; paramyxovirus; pneumonia; relapsed encephalitis; zoonosis

Mesh：

Year:  2014        PMID： 25015510     DOI： 10.1016/B978-0-444-53488-0.00032-8

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  10 in total

1.  Hendra virus and Nipah virus animal vaccines.

Authors:  Christopher C Broder; Dawn L Weir; Peter A Reid
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

2.  The Use of Large-Particle Aerosol Exposure to Nipah Virus to Mimic Human Neurological Disease Manifestations in the African Green Monkey.

Authors:  Ji Hyun Lee; Dima A Hammoud; Yu Cong; Louis M Huzella; Marcelo A Castro; Jeffrey Solomon; Joseph Laux; Matthew Lackemeyer; J Kyle Bohannon; Oscar Rojas; Russ Byrum; Ricky Adams; Danny Ragland; Marisa St Claire; Vincent Munster; Michael R Holbrook
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

Review 3.  Henipavirus infection of the central nervous system.

Authors:  Brian E Dawes; Alexander N Freiberg
Journal:  Pathog Dis       Date:  2019-03-01       Impact factor: 3.166

4.  Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus.

Authors:  Yu Cong; Margaret R Lentz; Abigail Lara; Isis Alexander; Christopher Bartos; J Kyle Bohannon; Dima Hammoud; Louis Huzella; Peter B Jahrling; Krisztina Janosko; Catherine Jett; Erin Kollins; Matthew Lackemeyer; Daniel Mollura; Dan Ragland; Oscar Rojas; Jeffrey Solomon; Ziyue Xu; Vincent Munster; Michael R Holbrook
Journal:  PLoS Negl Trop Dis       Date:  2017-04-07

5.  Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.

Authors:  Rebecca J Loomis; Guillaume B E Stewart-Jones; Yaroslav Tsybovsky; Ria T Caringal; Kaitlyn M Morabito; Jason S McLellan; Amy L Chamberlain; Sean T Nugent; Geoffrey B Hutchinson; Lisa A Kueltzo; John R Mascola; Barney S Graham
Journal:  Front Immunol       Date:  2020-06-11       Impact factor: 7.561

Review 6.  Nipah virus infection: A review.

Authors:  M Shariff
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 7.  Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review.

Authors:  Raj Kumar Singh; Kuldeep Dhama; Sandip Chakraborty; Ruchi Tiwari; Senthilkumar Natesan; Rekha Khandia; Ashok Munjal; Kranti Suresh Vora; Shyma K Latheef; Kumaragurubaran Karthik; Yashpal Singh Malik; Rajendra Singh; Wanpen Chaicumpa; Devendra T Mourya
Journal:  Vet Q       Date:  2019-12       Impact factor: 3.320

Review 8.  Nipah Virus: Past Outbreaks and Future Containment.

Authors:  Vinod Soman Pillai; Gayathri Krishna; Mohanan Valiya Veettil
Journal:  Viruses       Date:  2020-04-20       Impact factor: 5.048

9.  Detailed analysis of the pathologic hallmarks of Nipah virus (Malaysia) disease in the African green monkey infected by the intratracheal route.

Authors:  Curtis Cline; Todd M Bell; Paul Facemire; Xiankun Zeng; Thomas Briese; W Ian Lipkin; Joshua D Shamblin; Heather L Esham; Ginger C Donnelly; Joshua C Johnson; Lisa E Hensley; Anna N Honko; Sara C Johnston
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

10.  Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.

Authors:  Rebecca J Loomis; Anthony T DiPiazza; Samantha Falcone; Tracy J Ruckwardt; Kaitlyn M Morabito; Olubukola M Abiona; Lauren A Chang; Ria T Caringal; Vladimir Presnyak; Elisabeth Narayanan; Yaroslav Tsybovsky; Deepika Nair; Geoffrey B Hutchinson; Guillaume B E Stewart-Jones; Lisa A Kueltzo; Sunny Himansu; John R Mascola; Andrea Carfi; Barney S Graham
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.